Dr. Bin Tean Teh
National Cancer Center, USA

Email: Teh.bin.tean@singhealth.com.sg

Qualifications

Group Director, Translational Research, Singapore

Principal Investigator, National Cancer Centre, Singapore

Professor, Duke-NUS Graduate Medical School, Singapore

Professor, Center for Cancer Genomics and Computational Biology, Singapore

Head, Laboratory of Cancer Genetics, Singapore

Co-Head, Kidney Cancer Research Program, Singapore

Publications (Selected)

1. Larsson C, Calender A, Grimmond S, Giraud S, Hayward N, Teh BT, Farnebo F. Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1.J Int Med 238: 239–244, 1995
2. Teh BT, Silburn P, Linblad K, Betz R, Boyle R, Schalling M, Larsson C. Familial periodic cerebellar ataxia without myokimia maps to a 19-cM region on chromosome 19p13.Am J Hum Genet 56: 1443–1449, 1995
3. Cuneo RC, Hickman PE, Wallace JD, Teh BT, Ward G, Veldhuis JD, Walters MJ. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease.Clin Endocrinol 43: 265–275, 1995
4. Teh BT, Hansen J, Svensson PJ, Hartley L. Bilateral recurrent phaeochromocytoma associated with a growth hormone-secreting pituitary tumour.Br J Surg 83: 1132, 1996
5. Heath H 3rd, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV, Garrett JE, Leppert MF. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.J Clin Endocrinol Metab 81: 1312–1317, 1996
6. Grimmond SM, Teh BT, Hii SI, Cardinal J, Walters M, Epstein M, Edwards M, Hockey A, Pullan PT, Perry-Keene D, Boyages S, Cameron D, Hayward NK. Predictive diagnosis of multiple endocrine neoplasia (MEN1) in four Australian kindreds.Aust NZ J Med 26: 27–32, 1996
7. Grimmond SM, Palmer JM, Walters MK, Scott C, Nancarrow DJ, Teh BT, Elmes C, Pyke C, Khoo S, Bennett I, Wetzig N, Hayward NK. Confirmation of a susceptibility locus on chromosome 13 in Australian breast cancer families.Hum Genet 98: 80–85, 1996
8. Teh BT, McArdle J, Parameswaran V, David R, Larsson C, Shepherd J. Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1.Arch Surg 131: 1230–1232, 1996
9. Dotzenrath C, Teh BT, Farnebo F, Cupisti K, Svensson A, Toell A, Goretzki P, Larsson C. Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 81: 3194–3196, 1996
10. Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, Yap A, Epstein M, Heath H 3rd, Cameron D, Larsson C. Autosomal dominant primary hyperparathyroidism-jaw tumour syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild-type allele in renal hamartomas.J Clin Endocrinol Metab 81: 4204–4211, 1996
11. Sullivan AA, Teh BT, Jeavons S, Schalling M, Silburn P, Larsson C, Boyle R. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. J Clin Neuroscience 4: 176–180, 1997
12. Teh BT, Sullivan AA, Farnebo F, Zander C, Li FY, Strachan N, Schalling M, Larsson C, Sandstrom P. Oculopharyngeal muscular dystrophy (OPMD)--case report and genetic studies of an Australian kindred.Clin Genet 51: 52–55, 1997
13. Stock J, Warth M, Teh BT, Coderre JA, Overdorf JH, Baumann G, Hintz RL, Hartman ML, Seizinger BR, Larsson C, Aronin N. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to multiple endocrine neoplasia type 1 locus at chromosome region 11q13.J Clin Endocrinol Metab 82: 486–492, 1997
14. Teh BT, McArdle J, Chan SP, Mennon J, Hartley L, Pullen P, Ho J, Khir A, Wilkinson S, Larsson C, Cameron D, Shepherd J. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.Medicine 76: 21–29, 1997
15. Teh BT, Birrell G, Farrell A, Leonard H, Walters M, Palmer J, Ramsay J, Schlect D, Furnival C, Lavin M, Bennett I, Hayward N. Malignant breast cancer in six patients with neurofibromatosis type 1. Breast 6: 155–160, 1997
16. Lassam NJ, Lin Z, Shennan MG, Courseaux A, Teh BT, Gaudray P, Larsson C. Fine mapping of the MLK-3 gene within 11q13 and its exclusion as the MEN1 susceptibility gene. Hum Genet 99: 776–780, 1997
17. Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svensson A, White I, Betz R, Goretzki P, Sandelin K, Farnebo LO, Larsson C. Differential loss of heterozygosity in familial, sporadic and uremic hyperparathyroidism.Hum Genet 99: 342–349, 1997